Id. Dube et al., PRECLINICAL ASSESSMENT OF HUMAN HEMATOPOIETIC PROGENITOR-CELL TRANSDUCTION IN LONG-TERM MARROW CULTURES, Human gene therapy, 7(17), 1996, pp. 2089-2100
Long-term marrow cultures (LTMCs) were established from 27 human marro
ws. Hematopoietic cells were subjected to multiple rounds of exposure
to retroviral vectors during 3 weeks of culture. Seven different retro
viral vectors were evaluated. LTMCs were assessed for viability, repli
cation-competent retrovirus, progenitors capable of proliferating in i
mmune-deficient mice, and gene transfer. The average number of adheren
t cells and committed granulocyte-macrophage progenitors (CFU-GM) reco
vered from LTMCs was 28% and 11% of the input totals, respectively. Th
ere was no evidence by marker rescue assay or polymerase chain reactio
n (PCR) of replication-competent virus production during LTMC. No toxi
city to cellular proliferation due to the transduction procedure was o
bserved. The adherent layers of LTMCs exposed to retroviral vectors we
re positive for proviral DNA by PCR and by Southern blot analysis. Fif
ty-three percent of 1,427 individual CFU-GM from transduced LTMC adher
ent layers were positive for vector-derived DNA, For neo(r)-containing
vectors, the average G418 resistance was 28% of 1,393 LTMC-derived CF
U-GM. Forty percent of 187 tissues from 30 immune-deficient mice injec
ted with human LTMC cells were positive for human DNA 4-5 weeks after
adoptive transfer. These studies indicate that multiple exposures of h
uman LTMCs to retroviral vectors result in consistent and reproducible
LTMC viability and gene transfer into committed progenitors. Our resu
lts further support the use of transduced LTMC cells in clinical trial
s of hematopoietic stem cell gene transfer.